Current Testing Strategies for SARS-CoV-2 in the United States.

Cervinski, Mark A; Parnas, M Laura; Buxton, Barton P; Choi, Justin; Garner, Omai; Neath, Sean X; Zreloff, Jennifer L

Cervinski, Mark A; Parnas, M Laura; Buxton, Barton P; Choi, Justin; Garner, Omai; Neath, Sean X; Zreloff, Jennifer L.

Cervinski MA; Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Parnas ML; The Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Buxton BP; Roche Diagnostics Corporation, Indianapolis, IN, USA.
Choi J; McLaren Health Management Group, McLaren, Health Care, Davison, MI, USA.
Garner O; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Neath SX; Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Zreloff JL; Department of Emergency Medicine, University of California San Diego, San Diego, CA, USA.

Clin Chem ; 67(7): 935-940, 2021 07 06.

Article in English | MEDLINE | ID: covidwho-1387837

Subject(s)

COVID-19/diagnosis; COVID-19/virology; COVID-19 Testing/methods; Humans; Point-of-Care Systems; RNA, Viral/analysis; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2/genetics; SARS-CoV-2/isolation & purification; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Chem Journal subject: Chemistry, Clinical Year: 2021 Document Type: Article Affiliation country: CLINCHEM

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google